BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11079725)

  • 1. Hormonal treatment of endometrial cancer.
    Emons G; Heyl W
    J Cancer Res Clin Oncol; 2000 Nov; 126(11):619-23. PubMed ID: 11079725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal treatment of endometrial carcinoma.
    Baekelandt M
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):106-12. PubMed ID: 12113059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal therapy and chemotherapy of endometrial cancer].
    Krauss T; Huschmand H; Hinney B; Viereck V; Emons G
    Zentralbl Gynakol; 2002 Jan; 124(1):45-50. PubMed ID: 11873314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma.
    Karagol H; Saip P; Uygun K; Kucucuk S; Aydiner A; Topuz E
    Med Oncol; 2006; 23(4):543-8. PubMed ID: 17303913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of endometrial cancer.
    Barrena Medel NI; Bansal S; Miller DS; Wright JD; Herzog TJ
    Expert Opin Pharmacother; 2009 Aug; 10(12):1939-51. PubMed ID: 19586421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone therapy of endometrial carcinoma].
    Kuramoto H; Jobo T; Kato Y; Tateoka K; Sato R
    Gan To Kagaku Ryoho; 1996 May; 23(6):673-7. PubMed ID: 8645016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's new in systemic therapy for endometrial cancer.
    Kieser K; Oza AM
    Curr Opin Oncol; 2005 Sep; 17(5):500-4. PubMed ID: 16093803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer--a multicentre, open, controlled, prospectively randomised trial.
    von Minckwitz G; Loibl S; Brunnert K; Kreienberg R; Melchert F; Mösch R; Neises M; Schermann J; Seufert R; Stiglmayer R; Stosiek U; Kaufmann M
    Eur J Cancer; 2002 Nov; 38(17):2265-71. PubMed ID: 12441263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic therapy for advanced endometrial cancer].
    Tazi Y; Pautier P; Lhommé C
    Bull Cancer; 2012 Jan; 99(1):93-7. PubMed ID: 22236886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy in metastatic or recurrent endometrial carcinoma].
    Deppe G; Baumann P; Munkarah A
    Zentralbl Gynakol; 2000; 122(7):355-60. PubMed ID: 10951705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
    Gadducci A; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
    Ramirez PT; Frumovitz M; Bodurka DC; Sun CC; Levenback C
    Gynecol Oncol; 2004 Oct; 95(1):133-8. PubMed ID: 15385122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment options for endometrial cancer.
    Santin AD; Bellone S; O'Brien TJ; Pecorelli S; Cannon MJ; Roman JJ
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):679-89. PubMed ID: 15270671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal treatment of endometrial cancer: past, present and future.
    Podczaski E; Mortel R
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):469-89. PubMed ID: 11476566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic therapy for advanced endometrial cancer].
    Pautier P; Pommeret F
    Bull Cancer; 2017 Dec; 104(12):1046-1053. PubMed ID: 29157555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase in the context of breast and endometrial cancer. A review.
    Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
    Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
    De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
    J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endocrine therapy of solid tumors].
    Possinger K; Grosse Y; Petrides PE
    Internist (Berl); 1998 Nov; 39(11):1123-30. PubMed ID: 9859046
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinoma of the endometrium.
    Southcott BM
    Drugs; 2001; 61(10):1395-405. PubMed ID: 11558829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.